The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing
NCT ID: NCT04767958
Last Updated: 2022-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
89 participants
INTERVENTIONAL
2021-03-19
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spartan COVID-19 System: Evaluation of Clinical Sample Collection
NCT04473248
Evaluation of Clinical Performance and Usability of iStatis COVID-19 Ag Rapid Test at POC
NCT05514691
COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample
NCT04896710
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
NCT05584176
Novel Rapid POC Diagnostics for COVID-19
NCT05438589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This cohort will be divided into three groups:
1. patients consulted upon by ICU, internal medicine, or cardiology for admission to the hospital
2. patients undergoing cardiac testing and/or procedures
3. patients awaiting surgery The results from the POC test will be compared to the results from the traditional hospital core lab test to determine sensitivity and specificity of the POC test.
An additional cohort of 500 quarantined health care workers will have the POC test performed and compared with the results from the traditional hospital core lab test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients consulted upon by ICU, internal medicine, or cardiology for hospital admission
All patients will have both standard care and point-of-care (experimental) NP swabs performed.
Spartan COVID-19 Platform
Nasal-pharyngeal swab for testing on the Spartan Covid-19 platform
patients undergoing cardiac testing/procedures
All patients will have both standard care and point-of-care (experimental) NP swabs performed.
Spartan COVID-19 Platform
Nasal-pharyngeal swab for testing on the Spartan Covid-19 platform
patients awaiting surgery
All patients will have both standard care and point-of-care (experimental) NP swabs performed.
Spartan COVID-19 Platform
Nasal-pharyngeal swab for testing on the Spartan Covid-19 platform
Health Care Workers
Health Care Workers who are being screened for COVID-19 will have both standard care and point-of-care NP swabs performed.
Spartan COVID-19 Platform
Nasal-pharyngeal swab for testing on the Spartan Covid-19 platform
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spartan COVID-19 Platform
Nasal-pharyngeal swab for testing on the Spartan Covid-19 platform
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients for whom POC testing would change their course of treatment (in opinion of treatment team)
Exclusion Criteria
* patients in whom immediate COVID-19 testing would not alter short-term treatment
* patients who refuse consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ottawa Heart Institute Research Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20200858-01T
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.